Renee Matthews

Treating COVID-19 in patients with diabetes

Publish date: March 17, 2020

Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.

Publish date: March 7, 2020

The oral cortisol synthesis inhibitor is the first therapy approved by the agency to address the overproduction of cortisol.

Publish date: January 28, 2020

The once-daily therapy comprises the well-established medications empagliflozin, linagliptin, and metformin.

Publish date: January 21, 2020

It is the first drug to be approved for treatment of the debilitating, autoimmune condition.

Publish date: October 21, 2019

It is the first SGLT2 inhibitor approved in the United States for this indication in adults with type 2 disease.

Publish date: July 18, 2019

AstraZeneca says it has received a complete response letter, but gives no reason for the agency’s decision.

Publish date: May 8, 2019

LOS ANGELES – Yehuda Handelsman, MD, and Paul S. Jellinger, MD, summarized some of the key takeaways from this year’s...

Publish date: March 19, 2015